| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $43.2M | $58.3M | $22.1M |
| YoY Revenue Growth % | -26.0% | +163.4% | — |
| Gross Profit | $9.7M | -$7.2M | — |
| Gross Margin % | 22.5% | -12.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$65.8M | -$72.2M | -$40.7M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$56.9M | -$61.4M | -$25.6M |
| EBITDA (Normalized) | -$49.8M | -$63.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$25.0M | -$45.2M | -$23.0M |
| Capital Expenditures (CapEx) | $20.0M | $11.3M | — |
| Free Cash Flow (FCF) | -$45.0M | -$56.6M | -$23.0M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -29.4% | -23.2% | — |
| Cash & Short-Term Equivalents | $52.4M | $39.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $229.2M | $285.7M | — |